Global Gene Therapy Market Research and Forecast Report 2022-2027
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Gene Therapy Market Research Report: According to the latest report by IMARC Group, titled “ Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2 027 ,” the global gene therapy market reached a strong growth in 2021. Gene therapy refers to a medical technique that involves transfer of a new healthy gene to replace a defective gene in a cell. It aids in preventing disease progression by manipulating the expression of mutated genes or modifying the biological properties of living cells for therapeutic use. Some widely available gene therapy products include viral and bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy. Moreover, gene therapy is rapidly gaining traction to enhance the body’s ability to fight against various genetic disorders and chronic diseases that have no final cure yet. Request Free Sample Report: https://www.imarcgroup.com/gene-therapy-market/requestsample
Report Description and Highlights Report Description Global Gene Therapy Market Trends : The global gene therapy market is primarily driven by the growing incidences of inherited and acquired diseases, such as cancer, diabetes, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Additionally, the rising government support and funding for gene therapy research is another major growth-inducing factor. Furthermore, the leading players are developing advanced gene therapy products that offer a safer and non-addictive alternative to opioids in treating numerous chronic pain conditions like lower back pain, which is catalyzing the market growth. Other factors, including the aging population, increasing approvals of new gene therapy technologies, easy access to healthcare facilities, and technological advancements, are also anticipated to drive the market further. Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
Report Description and Highlights Report Description Market Summary: Breakup by Vector Type: • Viral Vector • Adenoviruses • Lentiviruses • Retroviruses • Adeno-Associated Virus • Herpes Simplex Virus • Poxvirus • Vaccinia Virus • Others • Non-Viral Techniques • Naked and Plasmid Vectors • Gene Gun • Electroporation • Lipofection • Others
Report Description and Highlights Report Description Breakup by Gene Type: • Antigen • Cytokine • Tumor Suppressor • Suicide Gene • Deficiency • Growth Factors • Receptors • Others Breakup by Delivery Method: • In-Vivo Gene Therapy • Ex-Vivo Gene Therapy Breakup by Application: • Oncological Disorders • Rare Diseases • Cardiovascular Diseases • Neurological Disorders • Infectious Disease • Others
Report Description and Highlights Report Description Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others •Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others
Report Description and Highlights Report Description •Latin America • Brazil • Mexico • Others •Middle East and Africa Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • •
Abeona Therapeutics Inc. Adaptimmune Therapeutics plc Adverum Biotechnologies Inc. Amgen Inc. Astellas Pharma Inc. Biogen Inc. Bluebird Bio Inc. Mustang Bio Inc. (Fortress Biotech Inc.) Novartis AG Orchard Therapeutics plc UniQure N.V. Voyager Therapeutics Inc.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/gene-therapy-market
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
We are the trusted business partners to the Partial Listworld's of Clients leading corporates, governments, and institutions
A partial List of our Clients
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com